Novo Integrated Sciences ... (NVOS)
undefined
undefined%
At close: undefined
0.11
243.03%
After-hours Nov 05, 2024, 07:58 PM EST

Company Description

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services.

It operates through two segments, Healthcare Services, and Product Manufacturing and Development.

The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.

It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations.

In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors.

Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions.

The company operates 16 owned clinics.

The company was incorporated in 2000 and is based in Bellevue, Washington.

Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

Novo Integrated Sciences Inc.
Novo Integrated Sciences Inc. logo
Country United States
IPO Date Feb 23, 2021
Industry Medical - Care Facilities
Sector Healthcare
Employees 127
CEO Robert Mattacchione

Contact Details

Address:
11120 NE 2nd Street
Bellevue, Washington
United States
Website https://novointegrated.com

Stock Details

Ticker Symbol NVOS
Exchange NASDAQ
Fiscal Year September - August
Reporting Currency USD
CIK Code 0001138978
CUSIP Number 67011T201
ISIN Number US67011T3005
Employer ID 59-3691650
SIC Code 3510

Key Executives

Name Position
Robert Mattacchione Chairman of the Board & Chief Executive Officer
Christopher Mehlin David Chief Operating Officer & Director
Dr. Joseph M. Chalil FACHE, M.B.A., M.D. Chief Medical Officer & Chairman of Medical Advisory Board
Vivek Sethi C.A., CPA Principal Financial Officer & Principal Accounting Officer

Latest SEC Filings

Date Type Title
Nov 29, 2024 NT 10-K Filing
Nov 29, 2024 8-K Current Report
Nov 20, 2024 DEFA14A Filing
Nov 20, 2024 8-K Current Report
Nov 14, 2024 DEFA14A Filing
Nov 14, 2024 8-K Current Report
Nov 06, 2024 8-K Current Report
Oct 31, 2024 8-K Current Report
Oct 23, 2024 8-K Current Report
Oct 17, 2024 DEF 14A Filing